本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Evaxion Biotech A/S

2.94
+0.21507.90%
成交量:28.05万
成交额:83.68万
市值:1,853.91万
市盈率:-0.49
高:3.09
开:2.85
低:2.81
收:2.72
数据加载中...
2024/01/12

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/22

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/07/07

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/06/01

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/05/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/25

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/22

SEC问询函

CORRESP [Cover] - Correspondence